
Yelena R Drexler MD
Acute Renal Failure, Chronic Renal Failure & Dialysis, Hypertension
Assistant Professor of Clinical Medicine
Join to View Full Profile
1450 NW 10th AveSte 1006Miami, FL 33136
Phone+1 305-243-6251
Fax+1 305-243-3506
Dr. Drexler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Fellowship, Nephrology, 2013 - 2015
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2010 - 2013
- Columbia University Vagelos College of Physicians and SurgeonsClass of 2010
Certifications & Licensure
- FL State Medical License 2018 - 2026
- NY State Medical License 2013 - 2019
- American Board of Internal Medicine Nephrology
- American Society of HypertensionHypertension Specialist
Publications & Presentations
PubMed
- Trends of preemptive kidney transplantation in lupus compared to other primary diseases leading to end stage kidney disease in the United States of America.Gabriel Contreras, Javier Pagan, Tali Elfassy, Miguel Bandes, Nicolas Bustamante
Lupus. 2025-07-01 - Clinical Outcomes in the Nephrotic Syndrome Study Network: Disease Burden and Treatment Patterns over Time.Yelena Drexler, Ambarish Athavale, Abigail R Smith, Qian Liu, Jarcy Zee
Glomerular Diseases. 2025-06-05 - Life's Essential 8, Cardiovascular Health, and CKD Progression among Hispanic/Latino Adults: The Hispanic Community Health Study/Study of Latinos Study.Amit K Chakrabarti, Yelena Drexler, Samuel Swift, James P Lash, Robert C Kaplan
Clinical Journal of the American Society of Nephrology. 2025-04-01
Press Mentions
- AION Healthspan Announces First Patient Treated in Phase I/II Clinical Trial for Cell Therapy in Chronic Kidney DiseaseMay 20th, 2025
- UHealth to Serve as Site for Chronic Kidney Disease Clinical TrialApril 2nd, 2025
- AION Healthspan Launches First-in-Human Clinical Trial for REJUVXL™ Cell Therapy in Chronic Kidney DiseaseMarch 2nd, 2025
- Join now to see all
Professional Memberships
- Member
- Member
Other Languages
- Russian, Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: